Anesthesia and Non-small Cell Lung Cancer Recurrence

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

5,384

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Non-small Cell Lung CancerSurgeryAnesthesia
Interventions
DRUG

Propofol

Propofol will be used for the induction and maintenance of general anesthesia.

DRUG

Inhaled anesthetics

Inhaled anesthetics will be used for the maintenance of general anesthesia.

Sponsors
All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Seoul St. Mary's Hospital

OTHER

collaborator

Korea University Guro Hospital

OTHER

collaborator

DongGuk University

OTHER

collaborator

Inha University Hospital

OTHER

collaborator

Konkuk University Medical Center

OTHER

collaborator

Ewha Womans University

OTHER

collaborator

Chungnam National University Hospital

OTHER

collaborator

University of Virginia

OTHER

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

collaborator

Yale University

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

University of Texas Southwestern Medical Center

OTHER

collaborator

University Hospitals Coventry and Warwickshire NHS Trust

OTHER

collaborator

Khon Kaen University

OTHER

collaborator

King Chulalongkorn Memorial Hospital

OTHER

collaborator

The Affiliated Hospital of Qingdao University

OTHER

collaborator

Beijing Hospital

OTHER_GOV

collaborator

All India Institute of Medical Sciences

OTHER

lead

Samsung Medical Center

OTHER

NCT06330038 - Anesthesia and Non-small Cell Lung Cancer Recurrence | Biotech Hunter | Biotech Hunter